Neuroprotective Activity of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (PAN-811), a Cancer Therapeutic Agent
Authors:
- 1 March 2006
- journal article
- review article
- Published by Wiley in CNS Drug Reviews
- Vol. 12 (1) , 77-90
Abstract
3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) is a highly-hydrophobic small molecule that was originally developed for cancer therapy (Triapine, Vion Pharmaceuticals) due to its ability to inhibit ribonucleotide reductase, a key enzyme required for DNA synthesis. 3-AP has a high affinity for divalent cations, chelating the Fe(2+) at the R2 subunit of the enzyme and inhibiting formation of a tyrosyl radical essential for ribonucleotide reduction. We have demonstrated that 3-AP is also a potent neuroprotectant (as such, it is referred to as "PAN-811"). In vitro it completely blocks ischemic neurotoxicity at a concentration of 0.5 microM (EC(50) approximate, equals 0.35 microM) and hypoxic toxicity at 1.2 microM (EC(50) approximate, equals 0.75 microM). Full protection of primary cortical and striatal neurons can be achieved with 3-AP when it is added to the medium at up to six hours after an ischemic insult. 3-AP also suppresses cell death induced by neurotoxic agents, including staurosporine, veratridine and glutamate, indicating activity against a central target(s) in the neurodegenerative process. 3-AP acts via neutralization of two important intracellular effectors of excitatory neurotoxicity; calcium and free radicals. Its reported ability to elevate anti-apoptotic proteins is likely to be a consequence of the suppression of excessive intracellular free calcium. In a rat model of transient ischemia, a single bolus delivery of 3-AP 1 h after the initiation of ischemic attack reduced infarct volume by 59% when administered i.c.v. (50 mug per rat) and by 35% when administered i.v. (1 mg/kg). In Phase I clinical trials in cancer therapy 3-AP had no cardiovascular, CNS or other major adverse effects. Thus, 3-AP has a high potential for development as a novel, potent neuroprotectant for the treatment of neurodegenerative diseases.Keywords
This publication has 54 references indexed in Scilit:
- PAN-811 (3-Aminopyridine-2-carboxaldehyde thiosemicarbazone), a novel neuroprotectant, elicits its function in primary neuronal cultures by up-regulating Bcl-2 expressionNeuroscience, 2005
- Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injuryJournal of Neurochemistry, 2004
- p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelatorCarcinogenesis, 2001
- Incorporation of sodium channel blocking and free radical scavenging activities into a single drug, AM‐36, results in profound inhibition of neuronal apoptosisBritish Journal of Pharmacology, 2001
- The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β‐amyloidEuropean Journal of Neuroscience, 2000
- Inhibitors of ribonucleotide reductaseBiochemical Pharmacology, 1994
- Tetrodotoxin-sensitive and-resistant effects of veratridine on the noradrenergic neurone of the rat vas deferensNaunyn-Schmiedeberg's Archives of Pharmacology, 1983
- Regulation of ribonucleotide reductase activity in mammalian cellsMolecular and Cellular Biochemistry, 1983
- Metabolic effects of zinc in intact cells—Comparative studies of zinc chloride and the zinc chelate of kethoxal bis(thiosemicarbazone)Biochemical Pharmacology, 1971
- Synergistic Interaction of Kethoxal bis(Thiosemicarbazone) and Cupric Ions in Sarcoma 180Nature, 1966